Neuroprotective agents in stroke
There has been much interest in agents that protect neurones in the ischaemic penumbra, yet to date these agents have proved ineffective in phase 3 trials.
Create an account to add page annotations
Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.